en
Scientific article
English

Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis

Published inMedical Decision Making, vol. 38, no. 6, p. 719-729
Publication date2018
Abstract

Decision makers often need to assess the real-world effectiveness of new drugs prelaunch, when phase II/III randomized controlled trials (RCTs) but no other data are available.

Citation (ISO format)
DIDDEN, Eva-Maria et al. Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis. In: Medical Decision Making, 2018, vol. 38, n° 6, p. 719–729. doi: 10.1177/0272989X18775975
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0272-989X
346views
0downloads

Technical informations

Creation09/03/2018 1:57:00 PM
First validation09/03/2018 1:57:00 PM
Update time03/15/2023 1:12:21 PM
Status update03/15/2023 1:12:20 PM
Last indexation10/19/2023 9:19:54 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack